Abstract:Jetty A Overbeek, 1, 2 Giel Nijpels, 2 Karin MA Swart, 1, 2 Marieke T Blom, 2, 3 Petra JM Elders, 2, 3 Ron MC Herings 1, 4 1 PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands; 2 Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of General Practice, Amsterdam, Netherlands; 3 Amsterdam Public Health, Health Behaviors & Chronic Diseases, Amsterdam, Netherlands; 4 Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam, Netherlands Correspondence: Jetty A Overbeek, Email Aims/Hypothesis: Only a few studies reported the incidence of type 2 diabetes (T2D). Understanding recent trends in diabetes is vital for planning future diabetes care. This study updated national trends in the prevalence and incidence of type 2 diabetes (T2D) in the Netherlands from 2004– 2020. Methods: The DIAbetes, MANagement and Treatment (DIAMANT) cohort was used. A cross-sectional design with yearly measurements for the study period was used. The prevalence was calculated by dividing the total number of people with T2D by the total number of all residents. The incidence was calculated by dividing new cases of T2D by the resident population at risk during the calendar year of interest. Results: Among men, the prevalence of T2D in the Netherlands increased from 2.3% in 2004 to 6.3% in 2020. Women's prevalence increased from 2.3% in 2004 to 5.3% in 2020. During 2005– 2009, the incidence rate for both men and women was relatively stable Between 2010 and 2020, the incidence rate fell about 1.5 per 1000 in both men and women. Conclusion: From 2004– 2020, the prevalence of T2D in the Netherlands more than doubled, with a decreasing incidence from 2010 onwards. Plain Language Summary: Research in context What is already known about this subject?Many studies have reported the increasing prevalence of type 2 diabetes (T2D). However, only a few studies reported the incidence.In a recent systematic review of all these studies, the incidence fell in over a third of the most high-income populations and increased in a minority of populations. Data from the Netherlands were included, but they date back to 1996.Understanding recent trends in diabetes, the prevalence and incidence are vital for planning future diabetes care.What is the key question?To update national trends in the prevalence and incidence of T2D in the Netherlands for 2004-2020.What are the new findings?During 2004-2020, the prevalence of T2D in the Netherlands more than doubled, with a decreasing incidence from 2010 onwards.How might this impact on clinical practice in the foreseeable future?It demonstrates the effectiveness of preventive strategies, public health education and awareness campaigns contributing to this trend. Keywords: type 2 diabetes, prevalence, incidence, epidemiology Type 2 diabetes (T2D) is a severe public health concern with a high impact on human life and health expenditure. Many studies worldwide have reported the increasing prevalence of T2D. Only a few studies reported the incidence. In a systematic review of all these studies, the incidence fell in over a third of the most high-income populations and increased in a minority of populations. 1 The countries that showed stable or decreasing trends from 2005 on were Europe and East Asia. Understanding trends in diabetes, the prevalence and the incidence is vital for planning future diabetes care. This study aimed to update national trends in the prevalence and incidence of T2D in the Netherlands for 2004–2020, in the total population and per sex and age category. Data for this study was obtained from the DIAbetes, MANagement and Treatment (DIAMANT) cohort. DIAMANT is a large and complete population-based, dynamic, prospective cohort of persons with diabetes derived from anonymized electronic medical records of Dutch general practitioners who consented to have their regular care electronic file extracted in the PHARMO General Practitioner (GP) Database for research purposes. The Dutch PHARMO GP data is a population-based database containing ~3.2 million Dutch inhabitants in 2020 (~20% of the Dutch population). 2,3 The PHARMO GP data are representative of the Dutch population with regard to the demographic characteristics (sex, age and degree of urbanization) and diagnoses in primary care. 3 The DIAMANT cohort contains structured information on people with diabetes using electronic GP information systems, eg examinations, medication, and diagnoses (including symptoms). In addition, the cohort contains basic information on all ci -Abstract Truncated-

Type 2 Diabetes, the Epidemic: Trends in Prevalence and Incidence, 2004-2020

Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings

Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014

Identifying and delineating the type 2 diabetes population in the Netherlands using an all-payer claims database: characteristics, healthcare utilisation and expenditures

Time trends in the incidence of clinically diagnosed type 2 diabetes and pre-diabetes in the UK 2009–2018: a retrospective cohort study

Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention

Trends in incidence and prevalence of type 1 diabetes between 1999 and 2019 based on the Childhood Diabetes Registry of Saxony, Germany

Trends in the Incidence of Type 1 Diabetes in European Children and Adolescents from 1994 to 2022: A Systematic Review and Meta‐Analysis

Diabetes type 2 in the Berlin Aging Study II: Cross-sectional and longitudinal data on prevalence, incidence and severity over on average seven years of follow-up

Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study

Changes in the incidence of type 2 diabetes in Australia, 2005–2019, overall and by socio‐demographic characteristics: a population‐based study

Incidence, Morbidity and years Lived With Disability due to Type 2 Diabetes Mellitus in 204 Countries and Territories: Trends From 1990 to 2019

Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013

Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends

Type 1 diabetes incidence and prevalence trends in a cohort of Canadian children and youth

Mining treatment patterns of glucose-lowering medications for type 2 diabetes in the Netherlands

Trends in childhood type 1 diabetes incidence in Europe during 1989–2008: evidence of non-uniformity over time in rates of increase

Exploring the Surge in Paediatric Type 2 Diabetes in an Inner-City London Centre—A Decade-Long Analysis of Incidence, Outcomes, and Transition

1-LB: Trends in Incidence and Age at Diagnosis of Youth-Onset Type 2 Diabetes, 2002–2018—The SEARCH for Diabetes in Youth Study

Prevalence of obesity and cardiovascular disease in adults with type 2 diabetes and use of diabetes medication in Germany: A claims data study

Prevalence, Deaths and Disability-Adjusted-Life-Years (DALYs) Due to Type 2 Diabetes and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019: Results From the Global Burden of Disease Study 2019